Vifor Fresenius Drug Patent Portfolio

Vifor Fresenius owns 1 orange book drug protected by 23 US patents Given below is the list of Vifor Fresenius's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10624855 Pharmaceutical composition, comprising phosphate binder particles 26 May, 2035
Active
US11234938 Pharmaceutical composition, comprising phosphate binder particles 26 May, 2035
Active
US11446252 Pharmaceutical composition, comprising phosphate binder particles 26 May, 2035
Active
US10624855 Pharmaceutical composition, comprising phosphate binder particles 26 Nov, 2034
Active
US11234938 Pharmaceutical composition, comprising phosphate binder particles 26 Nov, 2034
Active
US11446252 Pharmaceutical composition, comprising phosphate binder particles 26 Nov, 2034
Active
US9561251 Pharmaceutical compositions 23 Jul, 2030
Active
US9561251 Pharmaceutical compositions 23 Jan, 2030
Active
US10682376 Pharmaceutical compositions 13 May, 2029
Active
US10695367 Pharmaceutical compositions 13 May, 2029
Active
US10925896 Pharmaceutical compositions 13 May, 2029
Active
US10925897 Pharmaceutical compositions 13 May, 2029
Active
US10933090 Pharmaceutical compositions 13 May, 2029
Active
US11013761 Pharmaceutical compositions 13 May, 2029
Active
US11013762 Pharmaceutical compositions 13 May, 2029
Active
US10682376 Pharmaceutical compositions 13 Nov, 2028
Active
US10695367 Pharmaceutical compositions 13 Nov, 2028
Active
US10925896 Pharmaceutical compositions 13 Nov, 2028
Active
US10925897 Pharmaceutical compositions 13 Nov, 2028
Active
US10933090 Pharmaceutical compositions 13 Nov, 2028
Active
US11013761 Pharmaceutical compositions 13 Nov, 2028
Active
US11013762 Pharmaceutical compositions 13 Nov, 2028
Active
US6174442 Adsorbent for phosphate from an aqueous medium, production and use of said adsorbent 12 Jun, 2020 Expired


Given below is the list of recent legal activities going on the following drug patents of Vifor Fresenius.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 4th Year, Large Entity 11 Dec, 2023 US10682376
Payment of Maintenance Fee, 4th Year, Large Entity 11 Dec, 2023 US10695367
Payment of Maintenance Fee, 4th Year, Large Entity 09 Oct, 2023 US10624855
Recordation of Patent Grant Mailed 20 Sep, 2022 US11446252
Patent Issue Date Used in PTA Calculation 20 Sep, 2022 US11446252
Email Notification 01 Sep, 2022 US11446252
Issue Notification Mailed 31 Aug, 2022 US11446252
Dispatch to FDC 23 Aug, 2022 US11446252
Application Is Considered Ready for Issue 23 Aug, 2022 US11446252
Issue Fee Payment Verified 12 Aug, 2022 US11446252
Issue Fee Payment Received 12 Aug, 2022 US11446252
Mail Notice of Allowance 03 Aug, 2022 US11446252
Email Notification 03 Aug, 2022 US11446252
Electronic Review 03 Aug, 2022 US11446252
Notice of Allowance Data Verification Completed 01 Aug, 2022 US11446252


Vifor Fresenius Drug Patents' Oppositions Filed in EPO

Vifor Fresenius drug patents have faced multiple oppositions in the European Patent Office. The earliest opposition was filed on Sep 28, 2017, by Stada Arzneimittel Ag. This opposition was filed on patent number EP08848615A. Click below to reveal the latest opposition data.


Application Filing Date Opposition Party Legal Status
Patent litigations
EP08848615A Sep, 2017 Interquim S.A. Revoked
EP08848615A Sep, 2017 STADA Arzneimittel AG Revoked


Vifor Fresenius's Family Patents

Vifor Fresenius drugs have patent protection in a total of 34 countries. It's US patent count contributes only to 17.9% of its total global patent coverage. 3 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click below to unlock the full patent family tree.

Family Patents



Vifor Fresenius Drug List

Given below is the complete list of Vifor Fresenius's drugs and the patents protecting them.


1. Velphoro

Velphoro is protected by 23 patents, out of which 1 has expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10624855
(Pediatric)
Pharmaceutical composition, comprising phosphate binder particles 26 May, 2035
(10 years from now)
Active
US11234938
(Pediatric)
Pharmaceutical composition, comprising phosphate binder particles 26 May, 2035
(10 years from now)
Active
US11446252
(Pediatric)
Pharmaceutical composition, comprising phosphate binder particles 26 May, 2035
(10 years from now)
Active
US10624855 Pharmaceutical composition, comprising phosphate binder particles 26 Nov, 2034
(10 years from now)
Active
US11234938 Pharmaceutical composition, comprising phosphate binder particles 26 Nov, 2034
(10 years from now)
Active
US11446252 Pharmaceutical composition, comprising phosphate binder particles 26 Nov, 2034
(10 years from now)
Active
US9561251
(Pediatric)
Pharmaceutical compositions 23 Jul, 2030
(5 years from now)
Active
US9561251 Pharmaceutical compositions 23 Jan, 2030
(5 years from now)
Active
US10682376
(Pediatric)
Pharmaceutical compositions 13 May, 2029
(4 years from now)
Active
US10695367
(Pediatric)
Pharmaceutical compositions 13 May, 2029
(4 years from now)
Active
US10925896
(Pediatric)
Pharmaceutical compositions 13 May, 2029
(4 years from now)
Active
US10925897
(Pediatric)
Pharmaceutical compositions 13 May, 2029
(4 years from now)
Active
US10933090
(Pediatric)
Pharmaceutical compositions 13 May, 2029
(4 years from now)
Active
US11013761
(Pediatric)
Pharmaceutical compositions 13 May, 2029
(4 years from now)
Active
US11013762
(Pediatric)
Pharmaceutical compositions 13 May, 2029
(4 years from now)
Active
US10682376 Pharmaceutical compositions 13 Nov, 2028
(4 years from now)
Active
US10695367 Pharmaceutical compositions 13 Nov, 2028
(4 years from now)
Active
US10925896 Pharmaceutical compositions 13 Nov, 2028
(4 years from now)
Active
US10925897 Pharmaceutical compositions 13 Nov, 2028
(4 years from now)
Active
US10933090 Pharmaceutical compositions 13 Nov, 2028
(4 years from now)
Active
US11013761 Pharmaceutical compositions 13 Nov, 2028
(4 years from now)
Active
US11013762 Pharmaceutical compositions 13 Nov, 2028
(4 years from now)
Active
US6174442 Adsorbent for phosphate from an aqueous medium, production and use of said adsorbent 12 Jun, 2020
(4 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Velphoro's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List